NEONATAL ABSTINENCE SYNDROME
Clinical trials for NEONATAL ABSTINENCE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new NEONATAL ABSTINENCE SYNDROME trials appear
Sign up with your email to follow new studies for NEONATAL ABSTINENCE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Phone app aims to ease newborn opioid withdrawal through Mom's care
Disease control OngoingThis study is testing a mobile app designed to teach pregnant women with opioid use disorder how to care for their newborns who are at risk for Neonatal Abstinence Syndrome (NAS), a set of withdrawal symptoms. The goal is to see if the app is easy to use and helpful for mothers, …
Matched conditions: NEONATAL ABSTINENCE SYNDROME
Phase: NA • Sponsor: Washington State University • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Ear zaps ease Newborns' opioid withdrawal, study hopes
Symptom relief OngoingThis study is testing whether a gentle, non-invasive stimulation device worn on the ear can help newborns suffering from opioid withdrawal. The goal is to see if this 'ear stimulation' therapy can reduce the number of days babies need morphine and shorten their hospital stay. It …
Matched conditions: NEONATAL ABSTINENCE SYNDROME
Phase: NA • Sponsor: Spark Biomedical, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
AI steps in to help babies battling drug withdrawal
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to collect data to develop an artificial intelligence (AI) tool for newborns with Neonatal Abstinence Syndrome (NAS), a condition caused by drug exposure before birth. Researchers will gather information from 100 babies—80 with NAS and 20 healthy babies—to train t…
Matched conditions: NEONATAL ABSTINENCE SYNDROME
Sponsor: Rekovar Inc. • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC